Open AccessInitial report of a clinical trial evaluating the safety and efficiency of neoadjuvant camrelizumab and apatinib in patients with recurrent high-grade gliomas: A prospective, phase II, single-arm study
Author(s) -
Zhongping Chen,
Fuhua Lin,
Chengcheng Guo,
Qunying Yang,
Yinsheng Chen,
Chao Ke,
Ke Sai,
Ji Zhang,
Xiaobing Jiang,
Wanming Hu,
Shaoyan Xi,
Jian Zhou,
De-Pei Li,
Zhihuan Zhou,
Qinqin Zhao,
Xi Cao
Publication year - 2022
Publication title -
glioma
Language(s) - English
Resource type - Journals
eISSN - 2589-6121
pISSN - 2589-6113
DOI - 10.4103/glioma.glioma_6_22
Subject(s) - medicine , apatinib , glioma , radiation therapy , progression free survival , clinical trial , surgery , oncology , chemotherapy , phases of clinical research , survival rate , neoadjuvant therapy , cancer , breast cancer , cancer research